FDA Announces Recall for Penumbra Revascularization Device

The GMP Letter
A A
The FDA updated the status of a voluntary field removal notice for Penumbra’s 3D revascularization device, designating it as a Class I recall.

To View This Article:

Login

Subscribe To The GMP Letter